Navigation Links
Researchers develop gene therapy that could correct a common form of blindness
Date:1/23/2012

have this form, which affects the eye's inner lining.

"That was a great advance, which showed that gene therapy is safe and lasts for years in humans, but this new study has the potential for a bigger impact, because it is treating a form of the disease that affects many more people," said John G. Flannery, Ph.D., a professor of neurobiology at the University of California, Berkeley who is an expert in the design of viruses for delivering replacement genes. Flannery was not involved in the current study.

The X-linked form of retinitis pigmentosa addressed in the new study is the most common, and is caused by degeneration of light-sensitive cells in the eyes known as photoreceptor cells. It starts early in life, so though affected children are often born seeing, they gradually lose their vision.

"These children often go blind in the second decade of life, which is a very crucial period," said co-author Alfred S. Lewin, Ph.D., a professor in the UF College of Medicine department of molecular genetics and microbiology and a member of the UF Genetics Institute. "This is a compelling reason to try to develop a therapy, because this disease hinders people's ability to fully experience their world."

Both Lewin and Hauswirth are members of UF's Powell Gene Therapy Center.

The UF researchers and colleagues at the University of Pennsylvania performed the technically challenging task of cloning a working copy of the affected gene into a virus that served as a delivery vehicle to transport it to the appropriate part of the eye. They also cloned a genetic "switch" that would turn on the gene once it was in place, so it could start producing a protein needed for the damaged eye cells to function.

After laboratory tests proved successful, the researchers expanded their NIH-funded studies and were able to cure animals in which X-linked retinitis pigmentosa occurs naturally. The injected genes made their way only to the spot
'/>"/>

Contact: Czerne M. Reid
czerne@ufl.edu
352-273-5814
University of Florida
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers meet to refine carbon budget for US East Coast
2. Penn researchers help solve questions about Ethiopians high-altitude adaptations
3. Notre Dame researchers report fundamental malaria discovery
4. Researchers find gene critical to sense of smell in fruit fly
5. Native forest birds in unprecedented trouble, according to University of Hawaii at Manoa researchers
6. Researchers discover green pesticide for citrus pests
7. 2-timing and hybrids: RUB researchers look back on 100 million years of evolution
8. Researchers identify possible receptor for key breast cancer regulator
9. UH Manoa researchers discover novel chemical route to form organic molecules
10. Researchers: Honeybee deaths linked to seed insecticide exposure
11. Worm seeks worm: Caltech researchers find chemical cues driving aggregation in nematodes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
(Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... GSA BULLETIN science published online 9-20 March includes ... the Southern Pyrenees, and the western Gulf of Mexico. ... in south-central Chile, characterizing the source and age of ... pieces of mid-oceanic ridge found above ground, and large ...
... associated with storing nuclear waste and the possibility of ... may no longer be obstacles on the road to ... the University of Notre Dame, led by Thomas E. ... concurrent professor of chemistry and biochemistry, showcases Notre Dame ...
... WASHINGTON The water flowing through Venice,s famous canals ... not only because of a rising sea level. Although previous ... that the historic city continues to slowly sink, and even ... be continuing to subside, at a rate of about 2 ...
Cached Biology News:How old are these rocks, how were they made, and how long ago did these geologic changes happen? 2How old are these rocks, how were they made, and how long ago did these geologic changes happen? 3How old are these rocks, how were they made, and how long ago did these geologic changes happen? 4How old are these rocks, how were they made, and how long ago did these geologic changes happen? 5How old are these rocks, how were they made, and how long ago did these geologic changes happen? 6How old are these rocks, how were they made, and how long ago did these geologic changes happen? 7New paper by Notre Dame researchers describes method for cleaning up nuclear waste 2AGU: Venice hasn't stopped sinking after all 2AGU: Venice hasn't stopped sinking after all 3AGU: Venice hasn't stopped sinking after all 4
(Date:8/4/2015)... 4, 2015 Trigemina, Inc., a biopharmaceutical company ... delivered, analgesic drug products, announced today that the company ... of chief medical officer. Dr. Kori brings over 30 ... which has been focused in the neuroscience and headache ... Kori to our clinical team given his vast experience ...
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the ... selection of entrepreneurs from across the United States to talk about their experiences with ... to be chosen to be among the attendees. , One of the day’s aims ...
(Date:8/3/2015)... , August 3, 2015 At ... Portland Hospital waved the shortfall of Jude ... stand normally for the first time.      ... http://photos.prnewswire.com/prnh/20150803/254229 ) The Selective Dorsal ... allowing him to carry out his wish to kick ...
(Date:8/3/2015)... , Aug. 3, 2015  Aethlon Medical, Inc. (Nasdaq: ... devices to treat life-threatening diseases, today announced that it ... call and webcast on Thursday, August 13, 2015 at ... webcast will follow the release of fiscal 2016 first ... be available approximately two hours after the call at ...
Breaking Biology Technology:Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
... FRAZER, Pa., Dec. 6, 2010 Cephalon, Inc. (Nasdaq: ... company,s Chairman and Chief Executive Officer, will not be ... will remain on a medical leave of absence indefinitely.  ... Operating Officer, will continue to perform Dr. Baldino,s day-to-day responsibilities ...
... Dec. 6, 2010 Investigators report no evidence of toxicity ... a gene therapy trial using a vector under development ... College London) to correct the inherited bleeding disorder. ... with low and intermediate doses of the vector expected to ...
... SIGNAL HILL, Calif., Dec. 6, 2010 The medical ... recognized by the U.S. Department of Health and Human ... therapeutic discovery."  The designation earns the company a grant ... Project designation and grant is provided for under the ...
Cached Biology Technology:Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely 2Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 2Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 3Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 4Integrated Medical Systems' Technology Recognized as Qualified Therapeutic Discovery 2
... clone of the human Topoisomerase II gene. ... topological state of nucleic acids by passing an ... generates a separate DNA helix (1,2) . As ... the enzyme can relax negatively or positively supercoiled ...
RNase-Free DNase 50 l...
supplied with 10x reaction buffer...
... degrades, as an endoribonuclease, the RNA ... of natural origin, e.g. that of ... e.g. poly(A) x poly(dT). RNase H ... termini. Nearly no activity is detected ...
Biology Products: